Rui Yang

Rui Yang, Ph.D. MBA, serves as Marketing Director for Radioligand Therapy at Novartis, overseeing metastatic indication brand strategy and execution, as well as leading marketing strategies for breast cancer. Concurrently, Rui holds positions as Adjunct Professor of Marketing at NYU Stern School of Business, teaching healthcare marketing, and as Advisory Board Member for both Harvard Business Review and Fierce Life Sciences Events. Prior experience includes significant roles at Reckitt, Edgewell Personal Care, and Bayer Pharmaceuticals, focusing on brand strategy, innovation, and P&L management. Rui earned an MBA from NYU Stern and a Ph.D. in Chemistry from Stony Brook University, complemented by a B.S. from Shandong University.